AMG900 induces senescence in prostate cancer cells by upregulating p21.22 We also found that AMG900‐treated glioblastoma cells underwent senescence, with upregulated expression of p21 irrespective of whether they harbored a p53 mutation. Here, TP53 is linked to prostate carcinoma.